Genprex Strengthens Diabetes Gene Therapy Program with License … – BioSpace
Skip to main content Published: Dec 15, 2022 Technology for modulating autoimmunity expands intellectual property portfolio AUSTIN, Texas , Dec. 15, 2022 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a…